Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOX1 | Q06278 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4606349 | 1.00 | AOX1 (0.44) | AOX1LPAR3ACHESOAT2SOAT1 | |
| SCHEMBL4609010 | 0.80 | SOAT2 (0.46) | SOAT2SOAT1MEN1KMT2ATP53 | |
| SCHEMBL4609004 | 0.80 | SOAT2 (0.46) | SOAT2SOAT1MEN1KMT2ATP53 | |
| SCHEMBL4607989 | 0.78 | NR5A2 (0.37) | LPAR3SOAT2SOAT1CETPTP53 | |
| SCHEMBL4607987 | 0.78 | NR5A2 (0.37) | LPAR3SOAT2SOAT1CETPTP53 | |
| SCHEMBL4878268 | 0.78 | SOAT2 (0.47) | LPAR3SOAT2SOAT1CETPTSHR | |
| SCHEMBL4878263 | 0.78 | SOAT2 (0.47) | LPAR3SOAT2SOAT1CETPTSHR | |
| SCHEMBL31590883 | 0.78 | SOAT2 (0.47) | LPAR3SOAT2SOAT1CETPTSHR | |
| SCHEMBL21518324 | 0.75 | FAAH (0.44) | SOAT2SOAT1MEN1KMT2ATP53 | |
| SCHEMBL28328347 | 0.73 | CYP3A4 (0.45) | AOX1SOAT2SOAT1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1369422-B1 | PROCESS FOR PREPARATION OF ALKENYLPHOSPHINE OXIDES OR ALKENYLPHOSPHINIC ACID ESTERS | JAPAN SCIENCE & TECH AGENCY (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7135583-B2 | Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2006-11-14 | — | — | US | disclosed |
| US-20040059146-A1 | Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-03-25 | — | — | US | disclosed |
| EP-1369422-A1 | PROCESS FOR PREPARATION OF ALKENYLPHOSPHINE OXIDES OR ALKENYLPHOSPHINIC ACID ESTERS | Japan Science and Technology Corporation (JP) | 2003-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059146-A1 | Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters | PHOSPHO1, AGPS, AGPAT5 | AOX1 902/4885LPAR3 1908/4885ACHE 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.